文献速递瓣膜外科

二叶式主动脉瓣患者外科主动脉瓣置换术结局的基准分析

Benchmarking Outcomes of Surgical Aortic Valve Replacement in Patients With Bicuspid Aortic Valves.
PubMed 文献 · Ann Thorac Surg · 2023-07-15

基于美国1146家医院STS成人心脏数据库2011年7月1日至2018年12月31日孤立性外科主动脉瓣置换术患者并链接Medicare索赔数据,分析65,687例患者(二叶式9131例,13.9%)。二叶式患者较三叶式患者更年轻、预测死亡风险更低,风险校正30天死亡率和主要并发症相似,但风险校正5年死亡率显著更低(校正风险比0.72,95%CI 0.66-0.77),低风险患者中亦显著更低(校正风险比0.69,95%CI 0.64-0.76),且5年心力衰竭、卒中、出血或其他心血管原因再入院风险更低(均P<.05)。

要点

  • 二叶式患者较三叶式患者更年轻(中位70 vs 74岁)且STS预测死亡风险更低(均值1.6% vs 2.3%)。
  • 风险校正30天死亡率和主要并发症在二叶式与三叶式患者间相似。
  • 风险校正5年死亡率二叶式显著低于三叶式(校正风险比0.72,95%CI 0.66-0.77)。

核心结论

  • 在该全国代表性研究中,二叶式患者行孤立性外科主动脉瓣置换术的30天死亡率与三叶式患者相似,但风险校正5年死亡率显著更低,尤其在低风险和左心室射血分数正常患者中。

研究设计与样本

  • 分析美国1146家医院STS成人心脏数据库2011年7月1日至2018年12月31日所有行孤立性索引外科主动脉瓣置换术并链接Medicare索赔数据的患者。
  • 共分析65,687例患者,其中二叶式主动脉瓣患者9131例(13.9%)。

主要发现

  • 二叶式患者较三叶式患者显著更年轻(中位70 vs 74岁,P<.001),STS预测死亡风险评分更低(均值1.6% vs 2.3%,P<.001),风险特征更低。
  • 风险校正30天死亡率和主要并发症在二叶式与三叶式患者间相似。
  • 风险校正5年死亡率二叶式患者显著低于三叶式患者(校正风险比0.72,95%CI 0.66-0.77),低风险患者中亦显著更低(校正风险比0.69,95%CI 0.64-0.76)。
  • 二叶式队列5年心力衰竭、卒中、出血或其他心血管原因再入院风险更低(均P<.05)。

临床怎么用

  • 该分析提供了5年纵向全国层面基准,以更好地为二叶式患者经导管与外科主动脉瓣置换术的讨论提供信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The relative roles for transcatheter and surgical aortic valve replacement (SAVR) for bicuspid aortic valve (AV) stenosis are debated. This study analyzes the 5-year longitudinal outcomes of isolated SAVR in bicuspid vs tricuspid AV patients, particularly in low-risk patients. METHODS: All patients undergoing isolated index SAVR at 1146 United States hospitals in The Society of Thoracic Surgeons (STS) Adult Cardiac database between July 1, 2011, and December 31, 2018, with linkage to Medicare claims, were analyzed. RESULTS: A total of 65,687 patients were analyzed, including of 9131 bicuspid patients (13.9%). Compared with tricuspid patients, bicuspid patients were significantly younger (median 70 vs 74 years, P < .001) with lower Society of Thoracic Surgeons predicted risk of mortality scores (mean 1.6% vs 2.3%, P < .001) and lower risk profile. Risk-adjusted 30-day mortality and major morbidity were similar, but risk-adjusted 5-year mortality was significantly lower in the bicuspid patients (adjusted hazard ratio, 0.72; 95% CI, 0.66-0.77), specifically in low-risk patients (adjusted hazard ratio, 0.69; 95% CI, 0.64-0.76). Additionally, the bicuspid cohort had a lower 5-year readmission risk of heart failure, stroke, bleeding, or other cardiovascular causes (all P < .05). CONCLUSIONS: In this nationally representative study, 30-day mortality was similar, but risk-adjusted 5-year mortality was significantly lower in bicuspid patients undergoing isolated SAVR compared with tricuspid patients, specifically low-risk and normal left ventricular ejection fraction patients. This analysis provides a much-needed 5-year longitudinal national-level benchmark to better inform the discussion of transcatheter vs SAVR in bicuspid patients.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Hirji SA, Wegermann Z, Vemulapalli S, et al. Benchmarking Outcomes of Surgical Aortic Valve Replacement in Patients With Bicuspid Aortic Valves. Ann Thorac Surg. 2023. PMID: 37454786. doi:10.1016/j.athoracsur.2023.06.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。